The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication treatments, such as chemotherapy, immunotherapy,

Survival rates for all cancers are increasing, but threats to federal funding and access to care jeopardize these advances.

The Cancer Research Institute launches a first-of-its-kind open-access database to help scientists better understand how the immune system responds to cancer treatments over time. The collaborative approach aims to overcome a longstanding challenge in immunotherapy research.

The five-year relative survival for all cancers combined has reached a milestone, according to the American Cancer Society.

BioVaxys Technology Corp. (CSE:BIOV) (USOTC:BVAXF) said it has reported positive early results from its Phase 1B/2 PESCO clinical study evaluating its cancer vaccine MVP-S in combination with pembrolizumab (Keytruda™) and low-dose cyclophosphamide in patients with recurrent epithelial ovarian cancer.

A Port Moody, B.C., mother of two says she had to wait three months after being diagnosed with breast cancer to see an oncologist. She worries that wait has cost her precious time. B.C. Cancer data shows that while wait times are improving,

After Corcept Therapeutics setback with relacorilant in Cushing syndrome last month, the company has bounced back with strong data in ovarian cancer, firming its share price. Corcept's stock fell sharply at the end of 2025 when the FDA turned down its marketing application for glucocorticoid receptor (GR) antagonist relacorilant (CORT-125134) for patients with hypertension secondary to Cushing syndrome (hypercortisolism).

Journal of the American Medical Association, showed colorectal cancer jumped from the fifth-leading cancer death in the early 1990s to the first. "We weren’t expecting colorectal cancer to rise to this level so quickly,